Divalproex

Divalproex

Form: Extended-Release Tablets

Strength: 50 mg, 500 mg

Reference Brands: Depakote ER®(US)

Category: Antipsychotropic Drugs

Divalproex Extended-Release (ER) is a widely prescribed anticonvulsant and mood stabilizer used to treat epilepsy, bipolar disorder, and migraine prophylaxis. This formulation ensures sustained drug release, offering once-daily dosing and improved patient compliance. Marketed in the US under Depakote ER and available across the EU in multiple generic and branded forms, Divalproex ER is manufactured in strengths of 250 mg and 500 mg. Its versatility in neuropsychiatric and neurological conditions makes it a key product for global pharmaceutical sourcing. Ideal for B2B buyers looking to expand in CNS therapeutics, Divalproex ER meets stringent regulatory and quality standards.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Risperidone Long-Acting Injection

Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg vials/syringes

Form: Long-Acting Injection

Reference Brands: Risperdal Consta(US &EU)

View Details Get Enquiry
Zuclopenthixol ong-acting IM Injection (Depot)

Strength: 200 mg/mL, 500 mg/mL

Form: Long-acting IM Injection (Depot)

Reference Brands: Clopixol Depot®(US)

View Details Get Enquiry
Zuclopenthixol Short-acting Intramuscular Injection

Strength: 50 mg/mL

Form: Short-acting Intramuscular Injection

Reference Brands: Clopixol-Acuphase®

View Details Get Enquiry
Zuclopenthixol tablets

Strength: 10 mg, 25 mg, 40 mg

Form: Oral Tablets

Reference Brands: Clopixol®(EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.